News and Announcements
BitCar Welcomes New Team Members
- Published July 15, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- BitCar has welcomed several new members to the team this month
Meet the Team
BitCar has welcomed several new members to the team this month which include Andrew Barclay, Alejandro Aguilera, Zoe Panagopoulos and Olivier de Smedt. Each member brings forward their expertise and passion for the car industry.
Andrew joins the team as an advisor, bringing his experience in corporate legal advisory to BitCar. Alejandro has joined as our Senior Software Engineer, holding over 10 years’ experience in software architecture. Zoe is responsible for administrative duties and assistance on the daily operations to the BitCar team. Lastly a familiar face, Olivier joins BitCar as our Community developer. He brings on board his marketing experience to expand the community.
To learn more about our new members and their roles within the BitCar team click here.
About BitCar
In a world first, the BitCar platform allows fractionalized ownership and decentralized peer-to-peer trading in Exotic Cars with a new BITCAR token. Imagine being a part-owner of a Ferrari F40, Maserati MC12 or Bugatti Veyron just to name a few. Owners can peg their crypto to these hard assets for protection during times of high crypto volatility.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
